Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
Cephalon, Inc.announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R)...
Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc.
Bristol-Myers Squibb Company announced that it has completed its previously announced acquisition of ZymoGenetics, Inc.....
BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX for Treatment...
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that its...
AstraZeneca and PoZEN received approval for VIMOVO in Europe
AstraZeneca and POZEN Inc. today announced that VIMOVO (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets...
Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
Bexion Pharmaceuticals announced that it has been awarded a $1.5M Phase II Small Business Innovation...
Abbott Named One of the “Top Employers” in the Biotech and Pharmaceutical Industry by...
Abbott Park, Illinois was named one of the top 20 employers in Science magazine's 2010...
Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar
Pharma Major, Lupin Limited announced that its U.S subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has been...
Mylan Launches Generic Version of Wellbutrin XL(R) Tablets
Mylan Pharmaceuticals Inc. has launched Bupropion Hydrochloride Extended-release Tablets USP, (XL), 150 mg and 300...
Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology
Emisphere Technologies, Inc. announced that a clinical study found that the company's proprietary oral SNAC...
Movianto opens second warehouse in Orléans
Movianto France, the logistics and distribution company specialising in pharmaceuticals and healthcare has expanded its...
